AAAAAA

   
Results: 1-9 |
Results: 9
PHARMACEUTICAL FORMULATION OF AN INSOLUBLE AND UNSTABLE POTENT ALKYL TRANSFERASE INHIBITOR, PATRIN-2
Authors: OWENS MD HALBERT GW
Citation: Md. Owens et Gw. Halbert, PHARMACEUTICAL FORMULATION OF AN INSOLUBLE AND UNSTABLE POTENT ALKYL TRANSFERASE INHIBITOR, PATRIN-2, Annals of oncology, 9, 1998, pp. 182-182
FORMULATION AND STABILITY OF DMXAA INJECTION
Authors: HALBERT GW OWENS MD
Citation: Gw. Halbert et Md. Owens, FORMULATION AND STABILITY OF DMXAA INJECTION, Annals of oncology, 9, 1998, pp. 183-183
PHASE-I AND PHARMACOKINETIC STUDY OF D-LIMONENE IN PATIENTS WITH ADVANCED CANCER
Authors: VIGUSHIN DM POON GK BODDY A ENGLISH J HALBERT GW PAGONIS C JARMAN M COOMBES RC
Citation: Dm. Vigushin et al., PHASE-I AND PHARMACOKINETIC STUDY OF D-LIMONENE IN PATIENTS WITH ADVANCED CANCER, Cancer chemotherapy and pharmacology, 42(2), 1998, pp. 111-117
PRECLINICAL DEVELOPMENT OF THE ANTITUMOR AGENT CB-7646, BIS N-(HYDROXYMETHYL) TRIMETHYLMELAMINE, A STABLE ANALOG OF TRIMELAMOL
Authors: COLEY HM JARMAN M BROOKS N KUBOTA T GODDARD PM JONES M LEE N OWENS MD HALBERT GW JUDSON IR
Citation: Hm. Coley et al., PRECLINICAL DEVELOPMENT OF THE ANTITUMOR AGENT CB-7646, BIS N-(HYDROXYMETHYL) TRIMETHYLMELAMINE, A STABLE ANALOG OF TRIMELAMOL, International journal of cancer, 68(3), 1996, pp. 356-363
CONVERSION OF MITOMYCIN-C TO 2,7-DIAMINOMITOSENE AND 10-DECARBAMOYL 2,7-DIAMINOMITOSENE IN TUMOR-TISSUE IN-VIVO
Authors: CHIRREY L CUMMINGS J HALBERT GW SMYTH JF
Citation: L. Chirrey et al., CONVERSION OF MITOMYCIN-C TO 2,7-DIAMINOMITOSENE AND 10-DECARBAMOYL 2,7-DIAMINOMITOSENE IN TUMOR-TISSUE IN-VIVO, Cancer chemotherapy and pharmacology, 35(4), 1995, pp. 318-322
EFFECT OF PROCESS VARIABLES ON THE IN-VITRO DEGRADATION OF PROTEIN MICROSPHERES
Authors: MAGEE GA HALBERT GW WILMOTT N
Citation: Ga. Magee et al., EFFECT OF PROCESS VARIABLES ON THE IN-VITRO DEGRADATION OF PROTEIN MICROSPHERES, Journal of controlled release, 37(1-2), 1995, pp. 11-19
CRC EORTC/NCI JOINT FORMULATION WORKING PARTY - EXPERIENCES IN THE FORMULATION OF INVESTIGATIONAL CYTOTOXIC DRUGS/
Authors: BEIJNEN JH FLORA KP HALBERT GW HENRAR REC SLACK JA
Citation: Jh. Beijnen et al., CRC EORTC/NCI JOINT FORMULATION WORKING PARTY - EXPERIENCES IN THE FORMULATION OF INVESTIGATIONAL CYTOTOXIC DRUGS/, British Journal of Cancer, 72(1), 1995, pp. 210-218
ASSESSMENT OF POLYSACCHARIDE GELS AS DRUG-DELIVERY VEHICLES
Authors: MCTAGGART LE HALBERT GW
Citation: Le. Mctaggart et Gw. Halbert, ASSESSMENT OF POLYSACCHARIDE GELS AS DRUG-DELIVERY VEHICLES, International journal of pharmaceutics, 100(1-3), 1993, pp. 199-206
DEVELOPMENT OF A REPRODUCIBLE IN-VITRO METHOD FOR ASSESSING THE BIODEGRADATION OF PROTEIN MICROSPHERES
Authors: MAGEE GA WILLMOTT N HALBERT GW
Citation: Ga. Magee et al., DEVELOPMENT OF A REPRODUCIBLE IN-VITRO METHOD FOR ASSESSING THE BIODEGRADATION OF PROTEIN MICROSPHERES, Journal of controlled release, 25(3), 1993, pp. 241-248
Risultati: 1-9 |